Highbridge Capital Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Highbridge Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.96 - $2.93 $231,801 - $346,519	-118,266 Reduced 73.72%	42,154 $108,000
Q2 2022 Aug 11, 2022	SELL	$1.73 - $3.09 $73,806 - $131,828	-42,663 Reduced 21.01%	160,420 $310,000
Q1 2022 May 11, 2022	BUY	$2.94 - $4.77 $597,064 - $968,705	203,083 New	203,083 $603,000
Q4 2017 Feb 14, 2018	SELL	$17.45 - $25.6 $3.67 Million - $5.39 Million	-210,550 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$18.9 - $28.2 $3.98 Million - $5.94 Million	210,550	210,550 $5.29 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.